Gastroenterology

Latest News
March 14th 2024

FDA Approves Resmetirom, First Treatment for NASH With Liver Fibrosis

December 22nd 2023

Racial Variations in Curative Surgery Survival for Stage II/III Gastric Cancer

December 21st 2023

Korean Patients With IBD at Increased C Difficile Risk, Study Says

December 14th 2023

Adding Navy Beans to Diet Can Enhance Gut Microbiome, BE GONE Trial Finds

December 7th 2023

Black Patients With Ulcerative Colitis Less Likely to Undergo IPAA Than White Patients

Continuing Medical Education
View All
November 21st 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology
November 21st 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
November 21st 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

Vitamin D | Image credit: Cozine – stock.adobe.com
November 30th 2023

Vitamin D Linked to Clinical, Endoscopic Outcomes of Vedolizumab Treatment for IBD

Abigail Brooks, MA
Pretreatment vitamin D levels were associated with endoscopic improvement in patients with ulcerative colitis and decreased C-reactive protein levels in patients with Crohn disease.
digestive tact | Image credit: sdecoret - stock.adobe.com
November 21st 2023

Early Changes in PROs Are Linked With Treatment Response, Survival in Gastrointestinal Cancer

Skylar Jeremias
A cohort study found that early changes in patient-reported outcomes (PROs) were associated with treatment response and survival outcomes in patients with advanced gastrointestinal cancer, supporting the need for more routine implementation of PRO monitoring in cancer care spaces.
Irritable bowel syndrome | Photo credit: eddows - stock.adobe.com
November 14th 2023

Study Identifies Predictors of Fibromyalgia, Chronic Fatigue in IBS Patients

Abigail Brooks, MA
A retrospective analysis of data from the US National Inpatient Sample revealed the prevalence of fibromyalgia and chronic fatigue syndrome was significantly increased in patients with IBS compared with those without IBS.
FDA Approved | Image Credit: chrisdorney - stock.adobe.com.jpg
November 6th 2023

FDA Approves Erosive GERD Therapy Vonoprazan

Giuliana Grossi
Phathom Pharmaceuticals' vonoprazan (Voquenza) sets a new standard in erosive gastroesophageal reflux disease (GERD) therapy.
image of a woman and health care provider speaking
June 30th 2023

More Patient Support, Education Are Key in Improving IBS Management

Justina Petrullo
Accurate diagnosis, patient education, and collaborative decision making between patients and providers empowers patients with irritable bowel syndrome (IBS) to take their health into their own hands and stay out of the hospital.
Abstract image of the digestive tract
November 14th 2022

Presence of CRS May Indicate Potential to Develop Ulcerative Colitis

Maggie L. Shaw
Despite knowledge of chronic rhinosinusitis and inflammatory bowel diseases (IBDs) sharing dysfunctional mucosa, little is known of potential associations between sinusitis and IBD, which prompted this new study.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo